AHCO
AdaptHealth Corp. NASDAQ Listed May 31, 2018$11.74
Mkt Cap $1.6B
52w Low $8.06
68.5% of range
52w High $13.43
50d MA $11.35
200d MA $10.06
P/E (TTM)
-25.3x
EV/EBITDA
6.2x
P/B
1.2x
Debt/Equity
1.2x
ROE
-4.7%
P/FCF
6.1x
RSI (14)
—
ATR (14)
—
Beta
1.50
50d MA
$11.35
200d MA
$10.06
Avg Volume
1.4M
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
220 West Germantown Pike · Plymouth Meeting, PA 19462 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | BMO | 0.34 | 0.27 | -20.6% | 8.86 | -0.5% | +5.3% | +0.0% | -2.7% | +0.8% | +5.4% | — |
| Nov 4, 2025 | BMO | 0.24 | 0.22 | -8.3% | 10.67 | -0.2% | -3.1% | +0.0% | -7.1% | -1.1% | -1.1% | — |
| Aug 5, 2025 | BMO | 0.15 | 0.01 | -93.3% | 10.11 | -0.1% | -2.6% | +0.0% | -5.8% | -1.0% | +1.5% | — |
| May 6, 2025 | BMO | 0.01 | 0.01 | +0.0% | 8.85 | -0.6% | -6.9% | +0.0% | +1.7% | +2.3% | +6.3% | — |
| Feb 25, 2025 | BMO | 0.25 | 0.39 | +56.0% | 10.64 | +0.0% | +4.3% | +0.0% | -0.1% | +2.6% | -3.3% | — |
| Nov 5, 2024 | BMO | 0.17 | 0.15 | -11.8% | 9.18 | +3.4% | +10.9% | +0.0% | -3.4% | +2.6% | +3.6% | — |
| Aug 6, 2024 | BMO | 0.19 | 0.21 | +10.5% | 8.66 | +1.8% | +4.8% | +0.0% | +4.4% | -0.6% | -0.1% | — |
| May 7, 2024 | BMO | 0.06 | 0.02 | -66.7% | 9.76 | -1.0% | -0.7% | +0.0% | -5.2% | +5.2% | -1.8% | — |
| Feb 27, 2024 | BMO | 0.20 | 0.64 | +220.0% | 10.00 | +2.0% | +2.7% | +0.0% | -0.4% | +2.8% | +0.6% | — |
| Nov 7, 2023 | BMO | 0.19 | 0.19 | +0.0% | 7.69 | -6.0% | -15.5% | +0.0% | +4.8% | +1.0% | +10.2% | — |
| Aug 8, 2023 | BMO | 0.11 | 0.16 | +45.5% | 14.68 | +2.0% | +0.6% | +0.0% | -5.2% | -0.9% | -0.3% | — |
| May 9, 2023 | BMO | 0.08 | 0.01 | -87.5% | 11.30 | -2.0% | -2.1% | +0.0% | -8.8% | +5.1% | +4.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 | Truist | Maintains | Buy → Buy | — | $12.17 | $12.26 | +0.7% | +1.2% | +3.7% | -0.9% | -0.6% | +0.6% |
| Feb 26 | Leerink Partners | Maintains | Outperform → Outperform | — | $9.33 | $9.35 | +0.2% | -2.7% | +0.8% | +5.4% | -2.5% | +2.9% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.34 | $10.27 | -0.7% | -7.1% | -1.1% | -1.1% | +1.5% | -2.3% |
| May 12 | Truist | Maintains | Buy → Buy | — | $8.57 | $9.00 | +5.0% | +6.3% | -0.9% | -1.4% | +1.6% | -0.2% |
| May 8 | RBC Capital | Maintains | Outperform → Outperform | — | $8.24 | $8.28 | +0.5% | +1.7% | +2.3% | +6.3% | -0.9% | -1.4% |
| Feb 27 | Baird | Maintains | Outperform → Outperform | — | $11.10 | $11.22 | +1.1% | -0.1% | +2.6% | -3.3% | -6.0% | +1.0% |
| Feb 26 | Truist | Maintains | Buy → Buy | — | $10.64 | $10.64 | +0.0% | +4.3% | -0.1% | +2.6% | -3.3% | -6.0% |
| Feb 26 | RBC Capital | Maintains | Outperform → Outperform | — | $10.64 | $10.64 | +0.0% | +4.3% | -0.1% | +2.6% | -3.3% | -6.0% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.64 | $10.64 | +0.0% | +4.3% | -0.1% | +2.6% | -3.3% | -6.0% |
| Feb 13 | UBS | Maintains | Buy → Buy | — | $8.95 | $8.99 | +0.4% | -0.2% | -1.7% | -0.5% | +3.0% | -2.6% |
| Nov 19 | RBC Capital | Maintains | Outperform → Outperform | — | $9.57 | $9.33 | -2.5% | +1.8% | -0.2% | +1.7% | -0.3% | +2.6% |
| Nov 15 | Truist | Maintains | Buy → Buy | — | $10.04 | $10.08 | +0.4% | -4.0% | -0.7% | +1.8% | -0.2% | +1.7% |
| Nov 6 | UBS | Maintains | Buy → Buy | — | $9.18 | $9.49 | +3.4% | +10.9% | -3.4% | +2.6% | +3.6% | +2.3% |
| Nov 6 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.18 | $9.49 | +3.4% | +10.9% | -3.4% | +2.6% | +3.6% | +2.3% |
| Nov 6 | Baird | Maintains | Outperform → Outperform | — | $9.18 | $9.49 | +3.4% | +10.9% | -3.4% | +2.6% | +3.6% | +2.3% |
| Aug 12 | RBC Capital | Maintains | Outperform → Outperform | — | $9.42 | $9.47 | +0.5% | -0.1% | +3.1% | +0.4% | +5.0% | +2.2% |
| May 15 | Truist | Maintains | Buy → Buy | — | $9.83 | $10.02 | +1.9% | +0.1% | +0.1% | +1.3% | -0.9% | -1.3% |
| Mar 4 | RBC Capital | Maintains | Outperform → Outperform | — | $10.52 | $10.66 | +1.3% | +0.6% | -2.0% | +1.1% | +4.6% | -1.0% |
| Feb 28 | UBS | Maintains | Buy → Buy | — | $10.00 | $10.20 | +2.0% | +2.7% | -0.4% | +2.8% | +0.6% | -2.0% |
| Feb 28 | Truist | Maintains | Buy → Buy | — | $10.00 | $10.20 | +2.0% | +2.7% | -0.4% | +2.8% | +0.6% | -2.0% |
| Jan 29 | UBS | Maintains | Buy → Buy | — | $7.09 | $7.02 | -1.0% | +3.8% | -1.4% | -0.6% | +1.4% | +2.0% |
| Nov 8 | BofA Securities | Downgrade | Neutral → Underperform | — | $7.69 | $7.23 | -6.0% | -15.5% | +4.8% | +1.0% | +10.2% | +11.5% |
| Nov 8 | Truist | Maintains | Buy → Buy | — | $7.69 | $7.23 | -6.0% | -15.5% | +4.8% | +1.0% | +10.2% | +11.5% |
| Nov 8 | RBC Capital | Maintains | Outperform → Outperform | — | $7.69 | $7.23 | -6.0% | -15.5% | +4.8% | +1.0% | +10.2% | +11.5% |
| Oct 11 | Truist | Maintains | Buy → Buy | — | $8.41 | $8.22 | -2.3% | -10.4% | -0.3% | -0.9% | -3.2% | +4.3% |
| Sep 22 | BofA Securities | Maintains | Neutral → Neutral | — | $8.66 | $8.61 | -0.6% | -0.7% | +2.3% | -0.6% | +0.3% | +0.7% |
| Jul 13 | Baird | Maintains | Outperform → Outperform | — | $12.74 | $13.03 | +2.3% | +0.5% | +4.3% | +0.9% | +7.2% | -0.8% |
| Jun 28 | Baird | Maintains | Outperform → Outperform | — | $11.28 | $11.27 | -0.1% | +2.9% | +3.1% | +1.7% | -1.6% | -0.3% |
| Jun 27 | Baird | Maintains | Outperform → Outperform | — | $9.43 | $9.41 | -0.2% | +19.6% | +2.9% | +3.1% | +1.7% | -1.6% |
| May 11 | RBC Capital | Maintains | Outperform → Outperform | — | $11.06 | $10.99 | -0.6% | -8.8% | +5.1% | +4.8% | -0.2% | +1.2% |
| May 10 | Baird | Maintains | Outperform → Outperform | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Deutsche Bank | Downgrade | Buy → Hold | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Truist | Maintains | Buy → Buy | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 10 | Stifel | Downgrade | Buy → Hold | — | $11.30 | $11.07 | -2.0% | -2.1% | -8.8% | +5.1% | +4.8% | -0.2% |
| May 9 | BofA Securities | Downgrade | Buy → Neutral | — | $12.07 | $10.86 | -10.0% | -6.4% | -2.1% | -8.8% | +5.1% | +4.8% |
| Apr 13 | Truist | Maintains | Buy → Buy | — | $12.08 | $12.14 | +0.5% | +0.7% | -1.7% | -1.6% | -0.9% | +2.1% |
| Mar 1 | Baird | Maintains | Outperform → Outperform | — | $15.99 | $15.95 | -0.3% | -5.4% | +2.4% | +3.2% | -6.6% | +0.8% |
| Nov 10 | SVB Leerink | Maintains | Outperform → Outperform | — | $20.72 | $21.79 | +5.2% | +9.1% | +1.0% | -3.9% | +0.0% | -2.0% |
| Sep 20 | Deutsche Bank | Maintains | Buy → Buy | — | $22.12 | $22.35 | +1.0% | -1.9% | -6.1% | -1.9% | -3.9% | +0.4% |
| Sep 19 | Truist | Maintains | Buy → Buy | — | $20.15 | $20.51 | +1.8% | +9.8% | -1.9% | -6.1% | -1.9% | -3.9% |
| Aug 10 | RBC Capital | Maintains | Outperform → Outperform | — | $22.24 | $21.84 | -1.8% | +5.3% | -1.0% | +1.9% | -1.8% | -5.1% |
| Aug 10 | SVB Leerink | Maintains | Outperform → Outperform | — | $22.24 | $21.84 | -1.8% | +5.3% | -1.0% | +1.9% | -1.8% | -5.1% |
| Jul 14 | Truist | Maintains | Buy → Buy | — | $19.44 | $19.56 | +0.6% | +0.9% | +2.7% | +0.6% | +0.0% | +2.8% |
| Mar 8 | RBC Capital | Maintains | Outperform → Outperform | — | $15.54 | $15.44 | -0.6% | +7.4% | +0.0% | -2.6% | -4.6% | -1.1% |
| Mar 2 | SVB Leerink | Maintains | Outperform → Outperform | — | $15.92 | $15.94 | +0.1% | -4.0% | -1.8% | +0.7% | +2.9% | +7.4% |
| Feb 18 | SVB Leerink | Maintains | Outperform → Outperform | — | $17.43 | $17.50 | +0.4% | -3.8% | -6.2% | -1.1% | -2.4% | +6.6% |
| Nov 5 | SVB Leerink | Maintains | Outperform → Outperform | — | $25.85 | $26.17 | +1.2% | -3.5% | +2.8% | -4.6% | +3.1% | -0.9% |
| Sep 27 | SVB Leerink | Maintains | Outperform → Outperform | — | $23.00 | $23.23 | +1.0% | +3.3% | -1.6% | -0.6% | +0.2% | +1.2% |
| Jul 14 | Baird | Upgrade | Neutral → Outperform | — | $26.27 | $26.83 | +2.1% | -2.6% | +0.7% | -1.1% | -5.9% | -4.6% |
No insider trades available.
8-K · 5.02
!!! Very High
AdaptHealth Corp. -- 8-K 5.02: Executive Change
AdaptHealth Corp. appointed Daniel McFadden as Chief Operating Officer while director Toby Scott Barnhart resigned, signaling potential management restructuring that investors should monitor for strategic implications.
May 5
8-K · 1.01
! Medium
Unknown — 8-K 1.01: Financing / Debt Agreement
BAC and AHCO's new debt agreement likely increases borrowing capacity and financial flexibility, which could support growth initiatives or improve balance sheet strength, benefiting shareholders if capital deployment is effective.
Apr 13
8-K
AdaptHealth Corp. -- 8-K Filing
AdaptHealth reported fourth-quarter and full-year 2025 financial results as a leading home healthcare provider offering medical equipment, supplies, and related services.
Feb 24
Data updated apr 24, 2026 4:42pm
· Source: massive.com